Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc XRTX


Primary Symbol: V.XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > XRTX.....slowly creeping higher
View:
Post by Iseneschal on Feb 28, 2024 2:20pm

XRTX.....slowly creeping higher

On low volume.
Now at top of "sideways channel " pattern ....$4.50 cad

Possible breakout....possible drop

Call it a coin toss


Place ur bet....either way ; )
Comment by Peggy123 on Feb 28, 2024 4:55pm
Wow  what an informative post actually USELESS  papi
Comment by Iseneschal on Mar 04, 2024 8:48am
Please explain yourself Peggy123 ....USELESS?
Comment by Iseneschal on Mar 05, 2024 10:58am
I will explain myself...... The reason for that post was to make people aware of the share price trend. XRTX is an inter-listed Co on both NASDAQ & The Canadian Exchange. Normally when a Co. listed on NASDAQ does a Financing.....I'd say 8 times out of 10 the share price will take a big hit. Given the fact that XRTX has now finished the 2nd tranche of it's 2 part finacing and the share ...more  
Comment by KOkidneydisease on Mar 05, 2024 7:51pm
Hi Iseneschal You've got great vision. I agree, I was waiting for the pull back after the financing to accumulate some more shares but I've decided XORTX is in the early stages of a preliminary run in anticipation of renewed partnership interest.  I'll look back but I believe at one point prior to the slow down in the BIOTECH area we were looking at possible valuations in $300 - ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities